AdBio Partners
Venture capital
UncertainLast verified 7 Nov 2026
AdBio Partners is a French venture capital firm focused on early-stage life sciences and therapeutic startup investments across Europe.
1 deal in the last 24 months, latest 16 Jan 2025. Derived from its deals in the news.
Key facts
- Stages
- Seed
- Sectors
- Biotech & pharma
- Eligible countries
- Not stated
- Provider based in
- France
- Timing
- Rolling applications
- Focus
- life sciences; early-stage startups; breakthrough medical discoveries; therapeutic innovations
- How to apply
- Apply route unknown
- Source
- https://adbio.partners/
Recent deals
| Company | Round | Sectors | Amount | Role | Announced |
|---|---|---|---|---|---|
| Cephagenix | Seed | Biotech & pharma | €9M | lead | 16 Jan 2025 |
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
AdBio partners is a VC firm with a strong entrepreneurial spirit, specialized in early-stage investment in the most promising life sciences startups in Europe.
https://adbio.partners/ - Sectors
breakthrough medical discoveries across various therapeutic areas and drive inventive European life sciences startups
https://adbio.partners/
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at AdBio Partners? Claim this profile to confirm what you invest in.